Skip to main content
. 2014 Feb;21(2):212–226. doi: 10.1128/CVI.00738-13

TABLE 1.

Outcome of immunized mice after live intranasal F. tularensis Schu S4 challenge

Immunization typea Immunization routeb Survival 14 days postchallenge
Time to death postchallengec
No. of survivors/total no. (%) Pd Avg ± SD (days) Pe
V (control) i.p./i.p., i.p./i.n., i.n./i.p./i.n. 0/34 (0) 4.9 ± 0.3
F. tularensis Schu S4-V i.p. 0/5 (0) NS 6.4 ± 0.9 <0.01
i.p./i.p. 1/10 (10) NS 6.8 ± 1.0 <0.001
i.p./i.n. 7/35 (20) 0.011 6.1 ± 0.9 <0.001
i.n./i.p. 2/8 (25) 0.033 6.3 ± 1.0 <0.01
i.n./i.p./i.n. 2/9 (22) 0.040 7.0 ± 0.8 <0.001
i.n./i.n. 0/11 (0) NS 5.5 ± 0.5 NS
i.n./i.n./i.n. 3/15 (20) 0.025 5.9 ± 0.8 <0.001
s.c./i.p., s.c./i.n., s.c./s.c. 0/30 (0) NS 5.7 ± 0.7 <0.001
a

Mice were immunized with control vesicles (V) or Schu S4-V at 2-week intervals by the indicated routes. Two weeks after the final immunization, all mice were challenged with ∼20 CFU (ranging from 3 to 49 CFU in different experiments) of F. tularensis Schu S4 by the intranasal route.

b

i.p., intraperitoneal; i.n., intranasal; s.c., subcutaneous.

c

Mean and standard deviation of time to death were calculated from only those animals that succumbed to infection.

d

Fisher's exact test, P value compared to that of control; NS, not significant.

e

One-way ANOVA, P value of Tukey posttest compared to that of control.